Ursodeoxycholic acid and endothelial-dependent, nitric oxide-independent vasodilatation of forearm resistance arteries in patients with coronary heart disease

British Journal of Clinical Pharmacology

Volumn 47, Issue 6, 1999, Pages 661-665

  Sinisalo, Juha ^a,d   Vanhanen, Hannu ^b   Pajunen, Pia ^a   Vapaatalo, Heikki ^c   Nieminen, Markku S ^a  

^a Division of Cardiology   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Dept of Pharmacol and Toxicology ^*  (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Coronary heart disease; Endothelium; Ursodeoxycholic acid

Indexed keywords

ACETYLCHOLINE; ADURSAL; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADULT; ARM BLOOD FLOW; ARTERY DILATATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOREARM; HUMAN; ISCHEMIC HEART DISEASE; MALE; ORAL DRUG ADMINISTRATION; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE BLOOD VESSEL;

ACETYLCHOLINE; ADULT; AGED; CORONARY DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; OMEGA-N-METHYLARGININE; URSODEOXYCHOLIC ACID; VASODILATION;

EID: 0032999801     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00940.x     Document Type: Article

References (24)

1. 1 Lüscher T, Tanner FC. Endothelial regulation of vascular tone and growth. Am J Hypertension 1993; 6: 283S-293S.
2. 2 Cohen R, Vanhoutte PM. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation 1995; 92: 3337-3349.
3. 3 Alexander R. Inflammation and coronary artery disease. N Engl J Med 1994; 331: 468-469.
4. 4 Libby P. Molecular basis of the acute coronary syndromes. Circulation 1995; 91: 2844-2850.
5. 5 Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide link. Lancet 1997; 349: 1391-1392.
6. 6 Rubin R, Kowalski TE, Khandelwal M, Malet PF. Ursodiol for hepatobiliary disorders. Ann Intern Med 1994; 121: 207-218.
7. 7 Invernizzi P, Salzman AL, Szabo C, Ueta I, O'Connor M, Setchell KDR. Ursodeoxycholate inhibits induction of NOS in human intestinal epithelial cells and in vivo. Am J Physiol 1997; 273: G131-G138.
8. 8 Güldütuna S, Deisinger B, Weiss A, et al. Ursodeoxycholate stabilizes phospholipid-rich membranes and mimics the effect of cholesterol:investigation on large unilamellar vesicles. Biochim Biophys Acta 1997; 1326: 265-274.
9. 9 Poupon R, Balkau B, Eschwege E, Poupon R and the UDCA-PBC study group. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991; 324: 1548-1554.
10. 10 Bomzon A, Ljubuncic P. Bile acids as endogenous vasodilators. Biochem Pharmacol 1995; 49: 581-589.
11. 11 Alanko J, Riutta A, Mucha I, et al. Adrenaline stimulates thromboxane and inhibites leukotriene synthesis in man. Eicosanoids 1992; 5: 169-175.
12. 12 Sinisalo J, Mattila K, Nieminen MS, et al. The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors and forearm basal nitric oxide production. J Antimicrob Chemother 1998; 41: 85-92.
13. 13 Whitney R. The measurement of volume changes in human limbs. J Physiol (Lond) 1953; 121: 1-27.
14. 14 Bohme E, Graf H, Schultz G,. Effects of sodium nitroprusside and other smooth muscle relaxant on cyclic GMP formation in smooth muscle and platelets. Adv Cyclic Nucl Res 1978; 9: 131-143.
15. 15 Chowienczyk P, Cockcroft JR, Ritter JM. Blood flow responses to intra arterial acetylcholine in man: effects of basal flow and conduit vessel length. Clin Sci 1994; 87: 45-51.
16. 16 Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; ii: 997-1000.
17. 17 O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme a reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95: 1126-1131.
18. 18 Green D, O'Driscoll G, Blanksby B, Taylor R. Lack of effect of vitamin E administration on basal nitric oxide function in male smokers and non-smokers. Clin Sci 1995; 89: 343-348.
19. 19 Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992; 90: 2548-2554.
20. 20 Webb D. The pharmacology of human blood vessels in vivo. J Vasc Res 1995; 32: 2-15.
21. 21 Pocock S: Crossover trials. In: Pocock S, ed. (Clinical trials: A practical approach. Bath, Great Britan: A Wiley Medical Publication, 1983; 110-121.
22. 22 Zeiher A, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in human. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391-401.
23. 23 Vane J, Änggård EE, Botting RM. Regulatory function of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
24. 24 Casino P, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilatation of hypercholesterolemic patients. Circulation 1993; 88: 2541-2547.